Details
Stereochemistry | RACEMIC |
Molecular Formula | C10H15NO |
Molecular Weight | 165.2322 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(CC(C)N)C=C1
InChI
InChIKey=NEGYEDYHPHMHGK-UHFFFAOYSA-N
InChI=1S/C10H15NO/c1-8(11)7-9-3-5-10(12-2)6-4-9/h3-6,8H,7,11H2,1-2H3
Molecular Formula | C10H15NO |
Molecular Weight | 165.2322 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:34:55 UTC 2023
by
admin
on
Fri Dec 15 15:34:55 UTC 2023
|
Record UNII |
OVB8F8P39Q
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
7411
Created by
admin on Fri Dec 15 15:34:55 UTC 2023 , Edited by admin on Fri Dec 15 15:34:55 UTC 2023
|
||
|
WIKIPEDIA |
PiHKAL
Created by
admin on Fri Dec 15 15:34:55 UTC 2023 , Edited by admin on Fri Dec 15 15:34:55 UTC 2023
|
||
|
WIKIPEDIA |
Designer-drugs-4-Methoxyamphetamine
Created by
admin on Fri Dec 15 15:34:55 UTC 2023 , Edited by admin on Fri Dec 15 15:34:55 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID7040578
Created by
admin on Fri Dec 15 15:34:55 UTC 2023 , Edited by admin on Fri Dec 15 15:34:55 UTC 2023
|
PRIMARY | |||
|
SUB130947
Created by
admin on Fri Dec 15 15:34:55 UTC 2023 , Edited by admin on Fri Dec 15 15:34:55 UTC 2023
|
PRIMARY | |||
|
C100230
Created by
admin on Fri Dec 15 15:34:55 UTC 2023 , Edited by admin on Fri Dec 15 15:34:55 UTC 2023
|
PRIMARY | |||
|
23239-32-9
Created by
admin on Fri Dec 15 15:34:55 UTC 2023 , Edited by admin on Fri Dec 15 15:34:55 UTC 2023
|
SUPERSEDED | |||
|
100000156859
Created by
admin on Fri Dec 15 15:34:55 UTC 2023 , Edited by admin on Fri Dec 15 15:34:55 UTC 2023
|
PRIMARY | |||
|
DB01472
Created by
admin on Fri Dec 15 15:34:55 UTC 2023 , Edited by admin on Fri Dec 15 15:34:55 UTC 2023
|
PRIMARY | |||
|
7594
Created by
admin on Fri Dec 15 15:34:55 UTC 2023 , Edited by admin on Fri Dec 15 15:34:55 UTC 2023
|
PRIMARY | |||
|
para-Methoxyamphetamine
Created by
admin on Fri Dec 15 15:34:55 UTC 2023 , Edited by admin on Fri Dec 15 15:34:55 UTC 2023
|
PRIMARY | para-Methoxyamphetamine (PMA; "Death", "Dr. Death"), also known as 4-methoxyamphetamine (4-MA), is a designer drug of the amphetamine class with serotonergic effects. Unlike other similar drugs of this family, PMA does not produce stimulant, euphoriant, or entactogen effects, and behaves more like an antidepressant in comparison,[citation needed] though it does have some psychedelic properties. | ||
|
200-577-0
Created by
admin on Fri Dec 15 15:34:55 UTC 2023 , Edited by admin on Fri Dec 15 15:34:55 UTC 2023
|
PRIMARY | |||
|
31721
Created by
admin on Fri Dec 15 15:34:55 UTC 2023 , Edited by admin on Fri Dec 15 15:34:55 UTC 2023
|
PRIMARY | |||
|
32757
Created by
admin on Fri Dec 15 15:34:55 UTC 2023 , Edited by admin on Fri Dec 15 15:34:55 UTC 2023
|
PRIMARY | |||
|
OVB8F8P39Q
Created by
admin on Fri Dec 15 15:34:55 UTC 2023 , Edited by admin on Fri Dec 15 15:34:55 UTC 2023
|
PRIMARY | |||
|
64-13-1
Created by
admin on Fri Dec 15 15:34:55 UTC 2023 , Edited by admin on Fri Dec 15 15:34:55 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
ENANTIOMER -> RACEMATE |
|
||
|
TARGET -> AGONIST |
|
||
|
ENANTIOMER -> RACEMATE |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
MINOR
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
The reporting threshold is▲ (IRA 1-Jan-2020) 0.05%
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|